Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 23, 1993 - Issue 6
Submit an article Journal homepage
10
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics of a new thienodiazepine platelet activating factor receptor antagonist (E6123) in laboratory animals. Is there a metabolic polymorphism in the rhesus monkey?

K. Kusano Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-Chome Tsukuba-shi, Ibaraki, 300-26, Japan
,
S. Tanaka Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-Chome Tsukuba-shi, Ibaraki, 300-26, Japan
,
Y. Abe Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-Chome Tsukuba-shi, Ibaraki, 300-26, Japan
,
S. Ida Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-Chome Tsukuba-shi, Ibaraki, 300-26, Japan
&
T. Yuzuriha Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-Chome Tsukuba-shi, Ibaraki, 300-26, Japan
Pages 589-598 | Received 01 Apr 1993, Published online: 22 Sep 2008

References

  • Cuss F. M., Dixson C. M., Barnes P. J. Effects of inhalated platelet-activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986; ii: 189–192
  • Eichelbaum M. Defective oxidation of drugs; pharmacokinetics and therapeutic implications. Clinical Pharmacokinetics 1982; 7: 1–22
  • Ellard G. A. Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis. Clinical Pharmacology and Therapeutics 1976; 19: 610–625
  • Evans T. W., Chung K. F., Rogers D. F., Barnes P. J. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. Journal of Applied Physiology 1987; 63: 479–484
  • Jacqz E., Hall S. D., Branch R. A. Genetically determined polymorphisms in drug oxidation. Hepatology 1986; 6: 1020–1032
  • Kusano K., Tanaka S., Kosaki T., Miyazawa S., Tadano K., Yuzuriha T. Pharmacokinetic studies of (S)-(+)-6-(2-chlorophenyl)-3-cyclopropanecarbonyl-8,11-dimethyl-2,3,4,5-tetrahydro-8H-pyrido-[4′,3′:4,5]-thieno-[3,2-f]-[1,2,4]-triazolo-[4,3-a]-[1,4]-diazepine (E6123) (I): absorption, distribution, metabolism, excretion and identification of metabolites in beagle dogs. Xenobiotic Metabolism and Disposition 1993; 8: 73–89
  • Ladu B. N., Eckerson H. W. The polymorphic paraoxonase/arylesterase isozymes in human serum. Federation Proceeding 1984; 43: 2338–2341
  • Miyazawa S., Okano K., Kusano K., Tadano K., Tanaka S., Yuzuriha T., Machida Y., Yamatsu I. Synthesis of 14C-labelled (S)-(+)-6-(2-chlorophenyl)-3-cyclopropanecarbonyl-8,11-dimethyl-2,3,4,5-tetrahydro-8H-pyrido-[4′,3′:4,5]-thieno-[3,2-f]-[1,2,4]-triazolo-[4,3-a]-[1,4]-diazepine (14C-E6123). Journal of Labelled Compounds and Radiopharmaceuticals 1991; 29: 1073–1077
  • Miyazawa S., Okano K., Shimomura N., Kawahara T., Asano O., Yoshimura H., Kawai T., Souda S., Yoshida Y., Sato T., Machida Y., Yamatsu I. A practical synthesis of optically active platelet-activating factor antagonist, (+)-6-(2-chlorophenyl)-3-cyclopropanecarbonyl-8,11-dimethyl-2,3,4,5-tetrahydro-8H-pyrido-[4′,3′: 4,5]-thieno-[3,2-f]-[1,2,4]-triazolo-[4,3-a]-[1,4]-diazepine, and its absolute configuration. Chemical and Pharmaceutical Bulletin 1992; 40: 521–523
  • Person C. G. A., Erjefalt I. Inflammatory leakage of macromolecules from the vascular compartment into the tracheal lumen. Acta Physiologica Scandinavica 1986; 126: 615–616
  • Sakuma Y., Muramoto K., Harada S., Katayama S., Tsunoda H., Katayama K. Inhibitory effects of a novel PAF antagonist E6123 on anaphylactic responses in passively and actively sensitized guinea pigs and passively sensitized mice. Prostaglandins 1991b; 42: 541–555
  • Sakuma Y., Tsunoda H., Shirato M., Katayama S., Yamatsu I., Katayama K. Pharmacological effects of oral E6123, a novel PAF antagonist, on biological changes induced by PAF inhalation in guinea pigs. Prostaglandins 1991a; 42: 463–472
  • Tsunoda H., Sakuma Y., Harada K., Muramoto K., Katayama S., Horie T., Shimomura M., Clark R., Miyazawa S., Okano K., Machida Y., Katayama K., Yamatsu I. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Arzneimittel-Forschung/Drug Research 1990; 40: 1201–1205
  • Wardlaw A. J., Moqbel R., Cromwell O., Kay A. B. Platelet-activating factor: A potent chemotactic and chemokinetic factor for human eosinophils. Journal of Clinical Investigation 1986; 78: 1701–1706
  • Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. Journal of Pharmacobio-Dynamics 1981; 4: 879–885

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.